KNTV Press Here July 14, 2024
Just a few days ago San Francisco based Igm Biosciences launched a successful ipo raising 125 million. The company is developing antibodies to treat blood cancers. Biotech is not my area of expertise. Fortunately, i have three other chairs at this desk and can invite people who are much smarter than i am to talk about the industry. This morning i would like to specifically talk with Genomic Research and crisper, this is a way of editing genes. I would like to talk most beabout the Positive Side of it what it will allow us to do and the lives it will save. You are looking inside the labs of bio...